Herpes Simplex Virus 2 (HSV-2) IgM Antibody Rapid Test
Detect HSV-2 IgM antibodies quickly. Aids in early detection of recent Herpes Simplex Virus 2 infection in human serum or plasma.

Why Choose reOpenTest Infectious Disease Kits?
Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.
Rapid Results
Provides rapid results in just 15-20 minutes.
Easy to Use
Simple lateral flow immunochromatographic assay.
Visual Result
Visual result aids in early detection.
Product Overview
The Herpes Simplex Virus 2 (HSV-2) IgM Antibody Rapid Test is a qualitative immunoassay for the detection of IgM antibodies to HSV-2 in human serum or plasma. This rapid test provides a visual result, aiding in the early detection of a recent HSV-2 infection. The test utilizes a lateral flow immunochromatographic assay to detect the presence of HSV-2 IgM antibodies, which are often indicative of a primary infection. Early detection of HSV-2 is crucial for initiating appropriate treatment and preventing transmission. The test is designed for use in clinical settings by trained personnel, offering rapid results to inform timely patient management and care.
Technical Specifications
Detection Target | HSV-2 IgM antibodies |
---|---|
Sample Type | Serum or Plasma |
Methodology | Immunochromatography (Lateral Flow Assay) |
Detection Range | Positive/Negative |
Reaction Time | 15-20 minutes |
Storage Conditions | 2-30u00b0C |
Shelf Life | 24 months |
Procedure & Interpretation
Step-by-Step Procedure
- Collect a serum or plasma sample from the patient.
- Apply the sample to the test device.
- Wait 15-20 minutes for the reaction to occur.
- Visually interpret the results based on the presence or absence of control and test lines.
Result Interpretation



Frequently Asked Questions
Technical Documents
Download product inserts and brochures for detailed information.
Related Products
Partner with reOpenTest
Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.